2018
DOI: 10.2147/jaa.s159400
|View full text |Cite
|
Sign up to set email alerts
|

Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities

Abstract: Epinephrine is the only effective treatment for anaphylaxis but studies routinely show underutilization. This is especially troubling given the fact that fatal anaphylaxis has been associated with delayed administration of epinephrine. Many potential barriers exist to the proper use of epinephrine during an anaphylactic reaction. This article will explore both patient-and physician-related factors, as well as misconceptions that all contribute to the underuse of epinephrine for the treatment of anaphylaxis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
69
0
5

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 94 publications
(75 citation statements)
references
References 59 publications
0
69
0
5
Order By: Relevance
“…3,7,16 The underuse of epinephrine by healthcare professionals can be explained by the complexity involved in establishing the diagnosis of anaphylaxis, lack of knowledge of how to administer epinephrine and use epinephrine auto-injectors, and misconceptions about epinephrine safety. 15,25 To help improving the appropriate use of epinephrine in patients diagnosed with anaphylaxis within the emergency setting, physician training programs should be implemented.…”
Section: Discussionmentioning
confidence: 99%
“…3,7,16 The underuse of epinephrine by healthcare professionals can be explained by the complexity involved in establishing the diagnosis of anaphylaxis, lack of knowledge of how to administer epinephrine and use epinephrine auto-injectors, and misconceptions about epinephrine safety. 15,25 To help improving the appropriate use of epinephrine in patients diagnosed with anaphylaxis within the emergency setting, physician training programs should be implemented.…”
Section: Discussionmentioning
confidence: 99%
“…22 Epinephrine is the cornerstone of anaphylaxis management but continues to be underutilized. [23][24][25] As a nonselective adrenergic agonist, epinephrine works rapidly to increase peripheral vascular resistance through vasoconstriction, to increase cardiac output, to reverse bronchoconstriction and mucosal edema, and to stabilize mast cells and basophils. 26,27 Despite underuse of rapidly acting epinephrine as first-line treatment, fatal anaphylaxis is a rare outcome, with population prevalence rates between 0.47 and 0.69 per million persons (0.25%-0.33% of anaphylaxis hospitalizations or ED visits).…”
Section: Executive Summarymentioning
confidence: 99%
“…At an anaphylaxis PEER of 12.9%, chemotherapy premedication is associated with a decreased risk of anaphylaxis. The NNT is 16 (range, [13][14][15][16][17][18][19][20][21][22][23][24][25].…”
Section: Policy Level Nomentioning
confidence: 99%
“…There are several reasons physicians may be reluctant to administer epinephrine. Potential reasons include uncertain diagnosis, fear of side effects, and fear of misusing the auto‐injector . In a survey of 207 ED providers in the US, only 9% used the agreed‐upon criteria established by the National Institute of Allergy and Infectious Diseases (NIAID) for diagnosis of anaphylaxis .…”
Section: Discussionmentioning
confidence: 99%
“…Potential reasons include uncertain diagnosis, fear of side effects, and fear of misusing the auto-injector. 25 In a survey of 207 ED providers in the US, only 9% used the agreedupon criteria established by the National Institute of Allergy and Infectious Diseases (NIAID) for diagnosis of anaphylaxis. 26 The low positive predictive value (68%) of these criteria makes it a challenge for ED providers given the need to have a broad differential diagnosis.…”
Section: Discussionmentioning
confidence: 99%